The Plot to ROB Lester Martinez of His Mandatory Title Shot!

Wrestling

السنة2026

شاهد الآن

0

The boxing business is sparking outrage once again! Following Hamzah Sheeraz's quick victory over Alem Begic to capture the vacant WBO super middleweight title, the alarm bells started ringing. It wasn’t because of the knockout itself, but due to the immediate narrative pushed by the official DAZN broadcast team, projecting a massive, multi-million dollar unification between Sheeraz and Saúl "Canelo" Álvarez. However, they completely ignored a "small" major detail in this equation: Guatemalan contender Lester Martínez. By winning the WBC interim super middleweight championship against Immanuwel Aleem, Martínez rightfully earned his mandatory status to face the winner of September's clash between Canelo Álvarez and Christian M'billi. Are we witnessing a dirty political move by promoters and networks to freeze Lester Martínez out for pure commercial greed? Will they offer him a "step-aside" purse to clear the path for a mega-fight? In this video, we pull back the curtain on the behind-the-scenes politics, the sports injustice in the making, and the historic impact a Canelo vs. Martínez showdown in Las Vegas would have on Latin boxing. What do you think will happen? Will boxing politics leave Lester Martínez out in the cold, or will justice prevail? Would you rather see a historic clash between Canelo and Martínez for Latin pride, or an absolute war in a rematch between Martínez and Christian M'billi? Let me know in the comments below! #boxing #boxeo #lestermartinez #caneloalvarez #hamzahsheeraz #boxingnews #CaneloMbilli #whataboutboxing #boxing2026 About Fair Use Section 107 of the Copyright Act provides the statutory framework for determining whether something is a fair use and identifies certain types of uses—such as criticism, comment, news reporting, teaching, scholarship, and research—as examples of activities that may qualify as fair use. No Copyright infringement intended. ALL RIGHT BELONG TO THEIR RESPECTIVE OWNERS.